These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1872899)

  • 1. Increased microsomal irreversible binding of phenytoin by valproic acid.
    Wang SL; Lai ML; Huang JD
    Biochem Pharmacol; 1991 Aug; 42(5):1143-4. PubMed ID: 1872899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.
    Riley RJ; Maggs JL; Lambert C; Kitteringham NR; Park BK
    Br J Clin Pharmacol; 1988 Nov; 26(5):577-88. PubMed ID: 3207562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on 5,5-diphenylhydantoin irreversible binding to rat liver microsomal proteins.
    Pantarotto C; Arboix M; Sezzano P; Abbruzzi R
    Biochem Pharmacol; 1982 Apr; 31(8):1501-7. PubMed ID: 7092941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between phenytoin, 5-(p-hydroxyphenyl)-5-phenylhydantoin and valproate in the rat.
    O'Leary TD; Sansom LN
    J Pharmacol Exp Ther; 1981 Mar; 216(3):613-6. PubMed ID: 6782238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between phenytoin and valproic acid: plasma protein binding and metabolic effects.
    Perucca E; Hebdige S; Frigo GM; Gatti G; Lecchini S; Crema A
    Clin Pharmacol Ther; 1980 Dec; 28(6):779-89. PubMed ID: 6777108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of valproic acid with phenytoin.
    Bruni J; Gallo JM; Lee CS; Perchalski RJ; Wilder BJ
    Neurology; 1980 Nov; 30(11):1233-6. PubMed ID: 6775245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenytoin metabolic activation: role of cytochrome P-450, glutathione, age, and sex in rats and mice.
    Roy D; Snodgrass WR
    Res Commun Chem Pathol Pharmacol; 1988 Feb; 59(2):173-90. PubMed ID: 3358010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predisposition to phenytoin hepatotoxicity assessed in vitro.
    Spielberg SP; Gordon GB; Blake DA; Goldstein DA; Herlong HF
    N Engl J Med; 1981 Sep; 305(13):722-7. PubMed ID: 6790991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent binding of phenytoin to protein and modulation of phenytoin metabolism by thiols in A/J mouse liver microsomes.
    Roy D; Snodgrass WR
    J Pharmacol Exp Ther; 1990 Mar; 252(3):895-900. PubMed ID: 2319474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro bioactivation of phenytoin to a reactive free radical intermediate by prostaglandin synthetase, horseradish peroxidase, and thyroid peroxidase.
    Kubow S; Wells PG
    Mol Pharmacol; 1989 Apr; 35(4):504-11. PubMed ID: 2539558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated free fatty acid concentrations in lipemic sera reduce protein binding of valproic acid significantly more than phenytoin.
    Dasgupta A; Crossey MJ
    Am J Med Sci; 1997 Feb; 313(2):75-9. PubMed ID: 9030671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of phenytoin clearance by valproic acid in normal subjects.
    Frigo GM; Lecchini S; Gatti G; Perucca E; Crema A
    Br J Clin Pharmacol; 1979 Dec; 8(6):553-6. PubMed ID: 391257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats.
    Yamazaki H; Komatsu T; Takemoto K; Saeki M; Minami Y; Kawaguchi Y; Shimada N; Nakajima M; Yokoi T
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenytoin--valproic acid interaction in rhesus monkey.
    Koch KM; Ludwick BT; Levy RH
    Epilepsia; 1981 Feb; 22(1):19-25. PubMed ID: 6781887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pregnancy and folic acid on phenytoin metabolism by rat liver microsomes.
    Blake DA; Collins JM; Miyasaki BC; Cohen F
    Drug Metab Dispos; 1978; 6(3):246-50. PubMed ID: 26544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P-450 dependent irreversible binding of 6-thiopurine to rat liver microsomal protein in vitro and protection by glutathione.
    Hyslop RM; Jardine I
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):163-73. PubMed ID: 31662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Felbamate in vitro metabolism by rat liver microsomes.
    Adusumalli VE; Wong KK; Kucharczyk N; Sofia RD
    Drug Metab Dispos; 1991; 19(6):1135-8. PubMed ID: 1687021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual effect of valproic acid on the pharmacokinetics of phenytoin.
    Lai ML; Huang JD
    Biopharm Drug Dispos; 1993 May; 14(4):365-70. PubMed ID: 8499586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma protein binding interaction between phenytoin and valproic acid in vitro.
    Monks A; Boobis S; Wadsworth J; Richens A
    Br J Clin Pharmacol; 1978 Dec; 6(6):487-92. PubMed ID: 365209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium valproate on plasma protein binding of diphenylhydantoin.
    Patsalos PN; Lascelles PT
    J Neurol Neurosurg Psychiatry; 1977 Jun; 40(6):570-4. PubMed ID: 20483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.